4Van HP, Hulshof MC, Van LJJ, et al. Preoperative chemoradio-therapy for esophageal or junctional cancer[ J]. N Engl J Med,2012 , 366(22):2074-2084.
5Shapiro J, Ten Kate FJ, Van Hagen P, et al. Residualesophageal cancer after neoadjuvant chemoradiotherapy frequentlyinvolves the mucosa and submucosa [ J ]. Ann Surg, 2013,258(5):678-688.
6Park JW, Kim JW, Choi EK, et al. Prognosis of esophagealcancer patients with pathologic complete response afterpreoperative concurrent chemoradiotherapy [ J ]. Int J RadiatOncol Biol Phys, 2011, 81(3) :691-697.
7Greenstein AJ, Litle VR,Swanson SJ,et al. Prognostic significanceof the number of lymph node metastases in esophageal cancer [ J ].J Am Coll Surg, 2008 , 206(2) :239-246.
8GUPta A,Roy S,Majumdar A, et al. A randomized study tocompare sequential chemoradiotherapy with concurrent chemora-diotherapy for unresectable locally advanced esophageal cancer[J]. Indian J Med Paediatr Oncol,2014,35( 1) :54-59.
9Zanoni A, Verlato G, Giacopuzzi S,et al. Neoadjuvant concur-rent chemoradiotherapy for locally advanced esophageal cancer ina single high-volume center[ J] . Ann Surg Oncol,2013,20( 6);1993-1999.
10Guerrero-Santoro J, Levine A S, Rapi-Otri V. Co-localization of DNA repair proteins with UV-induced DNA damage in locally irra- diated cells[ J] Methods Mol Biol,2011,682 (2) :149 -61.
